分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

KIF23 promotes triple negative breast cancer through activating epithelial-mesenchymal transition

Wei Jian, Xiao-Chong Deng, Amik Munankarmy, Oyungerel Borkhuu, Chang-Le Ji, Xue-Hui Wang, Wen-Fang Zheng, Yun-He Yu, Xi-Qian Zhou, Lin Fang

Journal:Gland Surgery

IF:2.95

DOI:10.21037/gs-21-19

PMID:34268078

Published:2021-06-01

research field:分子生物学毒理学兽医学药理学细胞生物学

Abstract

Background KIF23 is a member of kinesin family, recent researches indicate KIF23 plays an important role in the proliferation and migration of malignant cancer cells. While the function and specific molecule mechanism of KIF23 in triple negative breast cancer remains unclear. Methods QRT-PCR and immunohistochemistry were conducted to analyze expression of KIF23 in triple negative breast cancer tissues and paired paracancer tissues. CCK-8 assay, colony formation assay, wound healing assay and transwell assay were applied for exploring phenotype changing of triple negative breast cancer cell lines MDA-MB-231 and BT549 after siRNA-induced knockdown of KIF23. Several bioinformatic databases were used for predicting miRNAs that combing with KIF23 mRNA and verified by dual luciferase reporter assay. Western blot assay was performed to explore downstream signaling pathway of KIF23. Results KIF23 was overexpressed in triple negative breast cancer, knockdown of KIF23 by siRNA inhibited proliferation and migration of TNBC cell lines MDA-MB-231 and BT549. Mechanistically, knockdown of KIF23 resulted in the suppression of Epithelial-Mesenchymal Transition. Meanwhile, miR-195-5p was downregulated in TNBC, and dual luciferase reporter assay indicated miR-195-5p could combine with 3’UTR of KIF23 thus promoting degradation of KIF23. Conclusions KIF23 is a potential oncogene in triple negative breast cancer, miR-195-5p could combine with 3’UTR of KIF23. Our study reveals a new sight into triple negative breast cancer.

本文使用的Yeasen产品

购物车
客服
转染试用